FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome (2021)

First Author: Brevini T

Attributed to: PBC Predict: Prediction models and predictive biomarkers for primary biliary cholangitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.06.06.446781

Publication URI: http://dx.doi.org/10.1101/2021.06.06.446781

Type: Preprint